活血化瘀药

  • 网络blood-activating and stasis-resolving medicinal
活血化瘀药活血化瘀药
  1. 活血化瘀药对腹膜炎大鼠生成白三烯B4的影响

    Influence of Blood-activating and Stasis-eliminating Drugs on Leukotriene B_4 Production of Rats with Peritonitis

  2. 活血化瘀药组分配伍对不稳定型心绞痛患者Fas系统的影响

    Effect of Blood Circulation to the Drug Component Compatibility in Patients with Unstable Angina Fas System

  3. 活血化瘀药防治ESWL术后血尿、石街形成的临床观察

    Clinical Observation of Blood-Activating and Stasis-Resolving Herbs in Preventing Complications After ESWL

  4. 活血化瘀药对ccl4所致小鼠急性肝损伤的保护作用。

    Protective effect of blood-activiating and stasis-dissolving drugs on the acute liver injury in mice caused by ccl_4 .

  5. 文章提出瘀血与血液流变学存在着十分密切的关系,活血化瘀药在治疗消化性溃疡出血时能显著提高血液粘度.提高红细胞压积,降低血细胞沉降率及血沉K值。

    It demonstrated the close relationship existing between blood stasis and blood rheology and the effect of blood-activating and stasis-resolving drugs could be ascribed to the increase in the viscosity of blood and packed RBC volume as well as the reduction of ESR and its K value .

  6. 活血化瘀药促进神经细胞瓢附分于(NCAM)的表达,对神经再生可能具有促进作用。

    The Huoxue Huayu drugs enhanced the expression of neural cell adhesion molecule ( NCAM ), appeared to play a pivotal role in the neural regeneration . 6 .

  7. 结果提示:促正常内皮细胞或促受损内皮细胞分泌PGI2的不同侧重可能造成了活血化瘀药中养血药和破血药的差别。

    These results suggested that the difference of the secretion of PGI_2 between the normal endothelial cells stimulated and injured endothelial cells stimulated might be the difference between the drugs for nourishing blood and the drugs for cracking blood .

  8. 分别用尿激酶型纤溶酶原激活剂(u-PA)、组织型纤溶酶原激活剂(t-PA)激活纤溶酶原的纤溶试验,观察了20余种常用活血化瘀药对纤溶的影响。

    The effects of more than 20 drugs used to activate blood flow and remove blood stasis were observed , separately using urokinase plasminogen activator ( u-PA ) and tissue plasminogen activator ( t-PA ) as the test of fibrinolytic function .

  9. 桃仁、红花等活血化瘀药是此方的君药;

    Peach Seed and Safflower are principal drugs of this decoction ;

  10. 健脾益气活血化瘀药辅助治疗渗出性胸膜炎的疗效观察

    Observation of the Supplemental Effect of Chinese Drugs on Pleurisy With Effusion

  11. 活血化瘀药对不稳定性心绞痛患者纤溶活性的影响

    Effects of Blood Circulation Drugs on the Patients with Unstable Angina Fibrinolytic Activity

  12. 活血化瘀药对脑梗塞患者血液流变学的影响

    Influence of Blood - Activating and Stasis-Resolving Herbs on Blood Rheology in Cerebral Infarction

  13. 活血化瘀药对大鼠脑缺血再灌注血管源性脑水肿的影响

    Influence of blood-activating and stasis-eliminating drugs on angiogenic cerebral edema of rats after cerebral ischemia-reperfusion

  14. 活血化瘀药在药物整体分布中占12.86%。

    The share of drug for invigorating blood circulation and eliminating stasis was 12.86 % .

  15. 阑尾脓肿模型的制作及活血化瘀药的治疗作用

    Preparation of periappendicular Abscess Rat Model and Investigation on Therapeutic Effect of Huoxue Huayu Herbs

  16. 冠状动脉介入术前应用活血化瘀药对手术出血风险的影响

    Effect of Preoperative Application of Blood-Activating and Stasis-Removing Herbal Medicine on Operative Hemorrhage in Percutaneous Coronary Intervention

  17. 活血化瘀药有明显的在体神经元保护作用。

    The Huoxue Huayu drugs have the direct protective effects on the neurons in vivo . 3 .

  18. 使用种类最多的是活血化瘀药,其次是补虚药,再次是清热药、理气药、止血药。

    The most widely used types are blood circulation drugs , followed by a tonic medicine again antipyretic .

  19. 所以活血化瘀药在肿瘤的治疗过程中广泛应用。

    So the herbs for invigorating blood circulation and eliminating stasis are widely used in tumor treating process .

  20. 实验组采用内服活血化瘀药外擦患处方法进行治疗。

    Besides , those in the study group were orally administrated by medicine for activating blood circulation and eliminating stasis .

  21. 活血化瘀药对急性软组织运动损伤患者血液流变学的影响

    Effect of Medicine for Activating Blood Circulation and Eliminating Stasis on Hemorheology of Patients with Acute Sports Injury of Soft Tissue

  22. 2型糖尿病患者CD11b/CD18的表达及活血化瘀药对其的影响

    Effect of Chinese Herbal Medicine for Activating Blood Circulation to Remove Stasis on CDllb / CD18 Expression in Patients with Diabetes Mellitus Type 2

  23. 活血化瘀药显著恢复血供,改善血液循环,加快血管新生。

    The Huoxue Huayu drugs restored the blood flow significantly , improved the blood circulation , and enhanced the development of angiogenesis . 4 .

  24. 结论疏肝理气中药与活血化瘀药可改善有抑郁症状食管癌患者的精神症状,提高食管癌的局控率与病人的生存率。

    Conclusion Traditional chinese medicine can improve the mental condition of esophageal carcinoma patients with depression , increase the local control rate and survival rate .

  25. 丹参作为常用活血化瘀药,与放疗相结合组合疗法在临床应用较多,但丹参联合放疗达到增效、减副的作用机理少见相关报道。

    As a commonly used blood circulation drug , its clinical combination applications with radiotherapy are common , but its function mechanism is rarely reported .

  26. 中药干预用药频率以补肾药最高,补肾中又以补肾阳药最高,其次是活血化瘀药。

    Chinese intervention in the highest frequency of administration to kidney medicine , medicine kidney kidney yang turned around , followed by blood circulation drugs .

  27. 目的:探讨预防性应用活血化瘀药对大鼠脑缺血&再灌注所致血管源性脑水肿的作用。

    AIM : To discuss the effects of blood activating and stasis eliminating drugs on angiogenic cerebral edema of the rats following cerebral ischemia reperfusion .

  28. 因此,我们对真武汤加活血化瘀药的现代药理作用进行了研究。

    Therefore , the modern pharmacological effects of Zhenwu decoction plus medicinal herbs for activating blood on chronic pulmonary heart disease binding with heart failure were researched .

  29. 用药特点:前5类药物为补虚药、活血化瘀药、清热药、利水渗湿药、祛风湿药。

    Characteristic of using drugs : The first five classes of herbs were reinforcing drugs , promoting-circulation drug , clearing-heat drugs , inhibiting-damp drugs , dispel-wind drugs .

  30. 临床运用应必须针对病人体质状况、病情轻重、证候情况确立标本缓急,选择恰当作用程度的活血化瘀药。

    Clinically administration must point to patients'constitution , disease severity , and signs for detailed treatment plan , and select proper drugs of activating blood circulation to remove stasis .